Announcements Trials

Browse Landscape

Phase

Phase 1/2 4 Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 256 Carcinoma, Non-Small-Cell Lung 212 Ovarian Neoplasms 134 Lung Neoplasms 107 Esophageal Neoplasms 69 Triple Negative Breast Neoplasms 64 Stomach Neoplasms 58 Fallopian Tube Neoplasms 56 Squamous Cell Carcinoma of Head and Neck 52 Neoplasm Metastasis 50 Head and Neck Neoplasms 44 Esophageal Squamous Cell Carcinoma 43 Carcinoma, Ovarian Epithelial 42 Neoplasms 36 Endometrial Neoplasms 34 Uterine Cervical Neoplasms 32 Recurrence 29 Adenocarcinoma Of Esophagus 24 Adenocarcinoma of Lung 22 Urinary Bladder Neoplasms 21 Melanoma 20 Carcinoma, Squamous Cell 19 Carcinoma 18 Small Cell Lung Carcinoma 17 Prostatic Neoplasms 15 Breast Neoplasms, Male 15 Adenocarcinoma, Bronchiolo-Alveolar 13 Peritoneal Neoplasms 12 Inflammatory Breast Neoplasms 12 Testicular Neoplasms 10

Interventions

Gemcitabine 45 Cisplatin 34 Oxaliplatin 23 Capecitabine 17 Fluorouracil 13 Leucovorin 12 pembrolizumab 11 lenvatinib 11 durvalumab 10 S 1 (combination) 10 Irinotecan 10 Bevacizumab 8 apatinib 7 Nivolumab 7 tremelimumab 6 Trastuzumab 5 envafolimab 4 atezolizumab 4 Injections 4 Docetaxel 4 trametinib 3 titanium silicide 3 tislelizumab 3 irinotecan sucrosofate 3 camrelizumab 3 Radiotherapy 3 Drug Therapy 3 zanidatamab 2 toripalimab 2 surufatinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Biliary Tract Neoplasms × Paclitaxel × Clear all

NCT03818997 2020-02-05

DYNAMIC

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Withdrawn

Gastrointestinal

Biliary Tract Neoplasms, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡